Two Genesys co-creations listed on Fierce's Top 10 smartest deals in biopharma
24 Jun 2024
June 24, 2024 - The past couple of years have seen Big Pharmas whip out their wallets to place high-stake bets in the red-hot races for antibody-drug conjugates, radiopharmaceuticals and obesity drugs, to name a few. We wanted to take another look at some of the deals that have kept our attention.